| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.8M | — |
| Cost of Revenue | $155.6M | — |
| Gross Profit | -$104.8M | — |
| R&D Expense | $273.8M | -6.5% |
| SG&A Expense | $370.2M | -7.6% |
| Operating Income | -$748.7M | -8.0% |
| Pre-tax Income | -$763.6M | -11.2% |
| Income Tax | $6K | +50.0% |
| Net Income | -$784.2M | -13.6% |
| EPS (Basic) | -$1.78 | -2.9% |
| EPS (Diluted) | -$1.78 | -2.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $233.4M | -53.1% |
| Accounts Receivable | $31.9M | — |
| Inventory | $123.2M | +962.3% |
| Current Assets | $436.9M | -16.7% |
| Total Assets | $1.24B | +24.9% |
| Current Liabilities | $383.6M | +112.4% |
| Long-term Debt | $291.6M | +1064.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$576.7M | -87.8% |
| Investing Cash Flow | -$221.2M | -6.6% |
| Financing Cash Flow | $598.7M | +219.1% |
| Total Liabilities |
| $710.2M |
| +139.7% |
| Stockholders' Equity | $526.5M | -24.1% |